Tag: Leqembi market launch success
Pharmalittle: U.K. Review of Leqembi and Bavarian Nordic Earnings
Eisai and Biogen, two pharmaceutical companies, recently received approval in the U.K. for their Alzheimer's treatment, Leqembi. However, this approval comes with a caveat, as the U.K.'s cost-effectiveness watchdog agency issued draft guidance stating...